Physician profile
Peter E Biglin
NPI 1831187376
$2,186.01
in general payments reported to CMS, 2019-2025
19 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $175 · 2021: $305 · 2022: $558 · 2023: $685 · 2024: $63.77 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $528 · Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $527.80 |
| Food and Beverage | $332.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $616.45 | 2022-2024 | Iovera |
| Horizon Therapeutics Plc | $456.26 | 2019-2022 | |
| Stryker Corporation | $247.39 | 2019-2022 | |
| Vericel Corporation | $200.76 | 2019-2022 | |
| Almatica Pharma LLC | $138.88 | 2021 | |
| Smith+Nephew, INC. | $93.15 | 2020-2025 | |
| Fidia Pharma USA INC. | $75.41 | 2022-2023 | Hymovis |
| Depuy Synthes Sales INC. | $69.06 | 2019-2024 | Orthovisc, Monovisc |
| Zimmer Biomet Holdings, INC. | $48.21 | 2021 | |
| Pinnacle, INC | $44.15 | 2019-2020 | |
| Caerus Corp. | $41.27 | 2019 | |
| Nalu Medical, INC. | $34.77 | 2025 | Nalu Neurostimulation System |
| Pacira Therapeutics, INC. | $22.78 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.77 | 2023 | |
| Averitas Pharma INC. | $19.59 | 2023 | Qutenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $18.27 | 2022 | |
| Stimwave Technologies Incorporated | $13.96 | 2022 | |
| Ferring Pharmaceuticals INC. | $13.13 | 2022 | |
| Bioventus LLC | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Biglin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.